×
About 261 results

ALLMedicine™ Benign Essential Blepharospasm Center

Research & Reviews  121 results

Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractor...
https://doi.org/10.1177/1120672121991043
European Journal of Ophthalmology; Takahashi Y, Vaidya A et. al.

Feb 13th, 2021 - To examine the effectiveness of orbicularis oculi myectomy with disabling the muscle of Riolan in patients with benign essential blepharospasm refractory to botulinum toxin-A (BTX-A) injection. This retrospective, observational study included 25 p...

Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign E...
https://doi.org/10.1097/WNO.0000000000001171
Journal of Neuro-ophthalmology : the Official Journal of ... Czyz CN, Burns JA et. al.

Jan 20th, 2021 - Report the development of onabotulinumtoxinA neutralizing antibodies in patients treated consecutively for 20 years or longer for benign essential blepharospasm (BEB), hemifacial spasm (HFS), and Meige Syndrome. Prospective, randomized, cross-sect...

The good toxin: 10 years of experience with botulinum toxin A in the treatment of benig...
https://doi.org/10.1177/1120672120925630
European Journal of Ophthalmology; Lai KK, Kuk AK et. al.

May 25th, 2020 - To describe the efficacy and safety of botulinum toxin A (Botox) in patients with benign essential blepharospasm. Retrospective review of operation, injection, and medical records. Information of 29 patients (nine males) was reviewed, and the aver...

Myotomy In Situ for Essential Blepharospasm Refractory to Botulinum Toxin.
https://doi.org/10.1097/SAP.0000000000002182
Annals of Plastic Surgery; Lai HT, Chen AD et. al.

Dec 13th, 2019 - Full myectomy is recommended for benign essential blepharospasm (BEB) refractory to botulinum toxin (BT) treatment, but long-term swelling, scar contracture, hollow appearance, and unnatural contour of the eyelids are common postoperative complica...

Increased pupillary constriction velocity in benign essential blepharospasm associated ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548394
PloS One; Byun YS, Kim SE et. al.

Jun 4th, 2019 - We evaluated whether the pupillary light reflex is altered in benign essential blepharospasm patients. Twenty-three patients with benign essential blepharospasm, 47 with reflex blepharospasm, and 29 dry eye disease controls were included. Pupillar...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  133 results

Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractor...
https://doi.org/10.1177/1120672121991043
European Journal of Ophthalmology; Takahashi Y, Vaidya A et. al.

Feb 13th, 2021 - To examine the effectiveness of orbicularis oculi myectomy with disabling the muscle of Riolan in patients with benign essential blepharospasm refractory to botulinum toxin-A (BTX-A) injection. This retrospective, observational study included 25 p...

Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign E...
https://doi.org/10.1097/WNO.0000000000001171
Journal of Neuro-ophthalmology : the Official Journal of ... Czyz CN, Burns JA et. al.

Jan 20th, 2021 - Report the development of onabotulinumtoxinA neutralizing antibodies in patients treated consecutively for 20 years or longer for benign essential blepharospasm (BEB), hemifacial spasm (HFS), and Meige Syndrome. Prospective, randomized, cross-sect...

The good toxin: 10 years of experience with botulinum toxin A in the treatment of benig...
https://doi.org/10.1177/1120672120925630
European Journal of Ophthalmology; Lai KK, Kuk AK et. al.

May 25th, 2020 - To describe the efficacy and safety of botulinum toxin A (Botox) in patients with benign essential blepharospasm. Retrospective review of operation, injection, and medical records. Information of 29 patients (nine males) was reviewed, and the aver...

Myotomy In Situ for Essential Blepharospasm Refractory to Botulinum Toxin.
https://doi.org/10.1097/SAP.0000000000002182
Annals of Plastic Surgery; Lai HT, Chen AD et. al.

Dec 13th, 2019 - Full myectomy is recommended for benign essential blepharospasm (BEB) refractory to botulinum toxin (BT) treatment, but long-term swelling, scar contracture, hollow appearance, and unnatural contour of the eyelids are common postoperative complica...

Increased pupillary constriction velocity in benign essential blepharospasm associated ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548394
PloS One; Byun YS, Kim SE et. al.

Jun 4th, 2019 - We evaluated whether the pupillary light reflex is altered in benign essential blepharospasm patients. Twenty-three patients with benign essential blepharospasm, 47 with reflex blepharospasm, and 29 dry eye disease controls were included. Pupillar...

see more →

News  5 results

FDA OKs IncobotulinumtoxinA (Xeomin) First-Line in Blepharospasm
https://www.medscape.com/viewarticle/912928

May 12th, 2019 - PHILADELPHIA — The US Food and Drug Administration (FDA) has approved broadening the indication for incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals) as first-line therapy for blepharospasm in adult patients, the manufacturer has announced. Benig...

Botulinum Toxin Effective for Blepharospasm in Toxin-Naïve Patients
https://www.medscape.com/viewarticle/912886

May 9th, 2019 - PHILADELPHIA — IncobotulinumtoxinA (Xeomin, Merz Pharmaceuticals) conveys long-term safety and efficacy in patients with benign essential blepharospasm (BEB) who are botulinum toxin-naïve, new research suggests. BEB is a focal dystonia that causes...

As-Needed Jabs With New Drug for Blepharospasm Are Safe
https://www.staging.medscape.com/viewarticle/752573

Oct 30th, 2011 - October 31, 2011 (Orlando, Florida) — A new study shows that shorter injection intervals with incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals), given on an as-needed basis, are safe and effective. The study provides much-needed proof that it is ...

As-Needed Jabs With New Drug for Blepharospasm Are Safe
https://www.medscape.com/viewarticle/752573

Oct 30th, 2011 - October 31, 2011 (Orlando, Florida) — A new study shows that shorter injection intervals with incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals), given on an as-needed basis, are safe and effective. The study provides much-needed proof that it is ...

see more →

Patient Education  1 results see all →